Enduro Genetics Raises €12M to Transform the Efficiency of Biomanufacturing at Scale
Like
Add to favorites
Investments & Finance
Enduro Genetics Raises €12M to Transform the Efficiency of Biomanufacturing at Scale
Vegconomist • Feb 04, 2025
Danish biotech company Enduro Genetics has raised €12 million in Series A funding for their new patented “synthetic addiction” technology aimed at improving efficiency and reducing costs and emissions in biomanufacturing. The technology addresses the issue of declining productivity at an industrial scale by integrating a genetic plug-in that ensures only high-producing cells survive, leading to consistent and scalable manufacturing processes.

This funding round, supported by investors like Supernova Invest and NOON Ventures, brings Enduro’s total funding to €18 million. The company plans to use the funds to expand their technology platform and accelerate commercialization. Enduro’s innovative approach to biomanufacturing has the potential to revolutionize the industry, allowing manufacturers to scale sustainably and drive meaningful change in various sectors like biopharma, food, agriculture, and industrial production.
*This summary was generated using AI.
Read Full Article
BREAKING: Wales Announces Plans To Ban Greyhound Racing

Plant Based News

Feb 18, 2025

Vegan Egg Demand Soars Amid US Egg Shortage

Plant Based News

Feb 18, 2025